These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23267294)

  • 61. The autoimmune regulator gene (AIRE) is strongly associated with vitiligo.
    Tazi-Ahnini R; McDonagh AJ; Wengraf DA; Lovewell TR; Vasilopoulos Y; Messenger AG; Cork MJ; Gawkrodger DJ
    Br J Dermatol; 2008 Sep; 159(3):591-6. PubMed ID: 18616774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
    Quan C; Ren YQ; Xiang LH; Sun LD; Xu AE; Gao XH; Chen HD; Pu XM; Wu RN; Liang CZ; Li JB; Gao TW; Zhang JZ; Wang XL; Wang J; Yang RY; Liang L; Yu JB; Zuo XB; Zhang SQ; Zhang SM; Chen G; Zheng XD; Li P; Zhu J; Li YW; Wei XD; Hong WS; Ye Y; Zhang Y; Wu WS; Cheng H; Dong PL; Hu DY; Li Y; Li M; Zhang X; Tang HY; Tang XF; Xu SX; He SM; Lv YM; Shen M; Jiang HQ; Wang Y; Li K; Kang XJ; Liu YQ; Sun L; Liu ZF; Xie SQ; Zhu CY; Xu Q; Gao JP; Hu WL; Ni C; Pan TM; Li Y; Yao S; He CF; Liu YS; Yu ZY; Yin XY; Zhang FY; Yang S; Zhou Y; Zhang XJ
    Nat Genet; 2010 Jul; 42(7):614-8. PubMed ID: 20526339
    [TBL] [Abstract][Full Text] [Related]  

  • 63. VIT1/FBXO11 knockdown induces morphological alterations and apoptosis in B10BR mouse melanocytes.
    Li Y; Chen F; Lin F; Guan C; Wei X; Wan Y; Xu A
    Int J Mol Med; 2009 May; 23(5):673-8. PubMed ID: 19360327
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel FoxD3 Variant Is Associated With Vitiligo and Elevated Thyroid Auto-Antibodies.
    Schunter JA; Löffler D; Wiesner T; Kovacs P; Badenhoop K; Aust G; Tönjes A; Müller P; Baber R; Simon JC; Führer D; Pfäffle RW; Thiery J; Stumvoll M; Kiess W; Kratzsch J; Körner A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1335-42. PubMed ID: 26267147
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population.
    Tang XF; Zhang Z; Hu DY; Xu AE; Zhou HS; Sun LD; Gao M; Gao TW; Gao XH; Chen HD; Xie HF; Tu CX; Hao F; Wu RN; Zhang FR; Liang L; Pu XM; Zhang JZ; Han JW; Pan GP; Wu JQ; Li K; Su MW; Du WD; Zhang WJ; Liu JJ; Xiang LH; Yang S; Zhou YW; Zhang XJ
    J Invest Dermatol; 2013 Feb; 133(2):403-10. PubMed ID: 22951725
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genetics of inflammatory bowel disease: progress and prospects.
    Mathew CG; Lewis CM
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R161-8. PubMed ID: 14764625
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma.
    Spritz RA
    Genome Med; 2010 Oct; 2(10):78. PubMed ID: 20959028
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus.
    Nath SK; Kelly JA; Namjou B; Lam T; Bruner GR; Scofield RH; Aston CE; Harley JB
    Am J Hum Genet; 2001 Dec; 69(6):1401-6. PubMed ID: 11592035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Research Progressin Single Nucleotide Polymorphism of Vitiligo Susceptibility Gene].
    Miao Y; Zhang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):906-913. PubMed ID: 36325790
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
    LaBerge GS; Bennett DC; Fain PR; Spritz RA
    J Invest Dermatol; 2008 Jul; 128(7):1757-62. PubMed ID: 18200060
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genetic association of the catalase gene (CAT) with vitiligo susceptibility.
    Casp CB; She JX; McCormack WT
    Pigment Cell Res; 2002 Feb; 15(1):62-6. PubMed ID: 11837458
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo.
    Yazici AC; Erdal ME; Kaya TI; Ikizoglu G; Savasoglu K; Camdeviren H; Tursen U
    Arch Dermatol Res; 2006 Jun; 298(1):46-9. PubMed ID: 16691430
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel immunological and genetic factors associated with vitiligo: A review.
    Said-Fernandez SL; Sanchez-Domínguez CN; Salinas-Santander MA; Martinez-Rodriguez HG; Kubelis-Lopez DE; Zapata-Salazar NA; Vazquez-Martinez OT; Wollina U; Lotti T; Ocampo-Candiani J
    Exp Ther Med; 2021 Apr; 21(4):312. PubMed ID: 33717255
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.
    Wang X; Erf GF
    J Autoimmun; 2004 Feb; 22(1):21-30. PubMed ID: 14709410
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multiple genes and locus interactions in susceptibility to vitiligo.
    Smith AG; Sturm RA
    J Invest Dermatol; 2010 Mar; 130(3):643-5. PubMed ID: 20145641
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.
    Fain PR; Babu SR; Bennett DC; Spritz RA
    Pigment Cell Res; 2006 Feb; 19(1):51-7. PubMed ID: 16420246
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Contribution of HLA class II genes, DRB4*01:01, DRB1*07:01, and DQB1*03:03:2 to clinical features of Vitiligo disease in Iranian population.
    Ghaffarnia R; Saffarian Z; Shahbazi M; Zamani M
    Mol Biol Rep; 2022 Jan; 49(1):171-178. PubMed ID: 34686989
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Understanding mechanisms of autoimmunity through translational research in vitiligo.
    Strassner JP; Harris JE
    Curr Opin Immunol; 2016 Dec; 43():81-88. PubMed ID: 27764715
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between exonic polymorphisms of human leukocyte antigen-G gene and non-segmental vitiligo in the Korean population.
    Kim SK; Kwon HE; Jeong KH; Shin MK; Lee MH
    Indian J Dermatol Venereol Leprol; 2022; 88(6):749-754. PubMed ID: 35389019
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection.
    Xie B; Zhu Y; Shen Y; Xu W; Song X
    Expert Opin Ther Targets; 2023 Mar; 27(3):189-206. PubMed ID: 36947026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.